The International Federation of Pharmaceutical Manufacturers and
Associations (IFPMA), the global Biotechnology Industry Organization
(BIO) and the World Anti-Doping Agency (WADA) today announced the launch
of the 2 FIELDS 1 GOAL: Protecting the Integrity of Science and Sport campaign,
that aims to achieve the goals of the Joint Declaration on Cooperation
in the Fight against Doping in Sport (Joint Declaration).
The campaign creates a strong framework of collaboration and encourages
the voluntary cooperation of IFPMA and BIO member companies with WADA to
readily identify compounds with the potential for misuse by athletes and
to stop doping in sport.
The launch of the 2 FIELDS 1 GOAL campaign coincides with the
release of the Points to Consider: Identification of Compounds with
Potential for Doping Abuse and Sharing of Information with WADA (Points
to Consider) booklet. This resource provides biotechnology and
pharmaceutical companies with practical guidelines to identify compounds
with sports-related doping potential before they come to market. The Points
to Consider booklet also helps minimize misuse of compounds during
clinical trials, facilitates sharing of information and collaboration on
communications about medicines with known doping potential. In addition
to the booklet, campaign materials include a brochure and frequently
asked questions, which provide more insight into industry collaboration
against doping in sport.
"The 2 FIELDS 1 GOAL campaign aims to accomplish the goals that
were laid out in the Joint Declaration that IFPMA and BIO signed with
WADA," said Eduardo Pisani, IFPMA Director General. "Doping is a public
health issue and undermines the integrity of scientific innovation and
competitive sports. We are pleased to provide support that will help
companies determine if they have products in their pipelines that could
be abused by athletes, even before they come to market."
In July 2010, IFPMA and WADA signed the Joint Declaration to encourage
the voluntary cooperation of IFPMA member companies to fight doping in
sport and to assist in the development of detection methods. BIO signed
on to the Joint Declaration in June 2011. As an extension of this
Declaration, the Points to Consider booklet and the 2 FIELDS 1
GOAL campaign serve as a manual to help companies identify compounds
in all stages of development with the potential for misuse and allow for
the sharing of information between the companies and WADA in order to
develop testing and detection methods to detect illegal or illicit use
by athletes.
"Working closely with biotechnology and pharmaceutical companies to
identify new potential doping compounds before they are commercially
available will facilitate much faster development of detection methods,"
said David Howman, Director General of WADA. "In addition, the booklet
will allow the pharmaceutical industry to ensure their work is directed
at developing and delivering treatments and medicines for therapeutic
purposes."
No comments:
Post a Comment